0
Skip to Content
Home
Clinical Trial Search
Blog
Glassbury Cares Podcast
Giving/Donations
Alzheimer's FAQ
Privacy Policy
GlassBury
GlassBury
Login Account
Sign up
Login Account
Sign up
Home
Clinical Trial Search
Blog
Glassbury Cares Podcast
Giving/Donations
Alzheimer's FAQ
Privacy Policy
GlassBury
GlassBury
Home
Clinical Trial Search
Blog
Glassbury Cares Podcast
Giving/Donations
Alzheimer's FAQ
Privacy Policy
Login Account
Sign up
The Silent Crisis: Why Metabolic Syndrome May Be Fueling the Rise of Parkinson’s Disease
FDA, Clinical Trials, Awareness Corey Hubbard 9/22/25 FDA, Clinical Trials, Awareness Corey Hubbard 9/22/25

The Silent Crisis: Why Metabolic Syndrome May Be Fueling the Rise of Parkinson’s Disease

Parkinson’s Disease (PD) is perhaps the most well-known motor neurodegenerative disorder, relentlessly affecting movement and quality of life. Globally, it impacts approximately 1% of individuals aged over 60 years, making it the most common condition of its type

Read More
GlassBury AI Connects

Glassbury LLC

Since 2023


Keep In Touch

Join Our List

Thank you!

Made with Squarespace